We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App





Bio-Rad Showcases Comprehensive Range of Quality Control-Related Offerings

By LabMedica International staff writers
Posted on 20 Jul 2023

Bio-Rad Laboratories (Hercules, CA, USA) is showcasing its comprehensive range of quality control-related offerings at the American Association of Clinical Chemistry Annual Scientific Meeting & Clinical Lab Expo, AACC 2023, in Anaheim, Calif. More...

, July 23-27. At booth #3239 on the AACC 2023 exhibition floor, attendees can explore and learn about Bio-Rad’s leading QC products, including the new Cardiac Advance product, Exact Diagnostics branded infectious disease molecular quality controls & panels, the family of InteliQ Load-and-Go controls, and Unity Next Peer QC data management solutions.

At the Bio-Rad AACC booth, visitors can explore its new comprehensive, multi-analyte control optimized for high sensitivity Troponin testing. Containing the ten most tested cardiac analytes, Cardiac Advance Control offers a consolidated formula to monitor the precision of cardiac laboratory testing procedures in one comprehensive control. Additionally, Bio-Rad’s InteliQ Load-and-Go controls allow labs to transform their QC workflow with load-and-go efficiency. InteliQ quality controls empower labs by automating workflow - reducing turnaround time, limiting manual errors, and increasing overall efficiency. Visitors to the company’s booth can also learn more about its latest offering, Unity Next Peer QC, which is a simple peer comparison tool with instant access to peer reporting in a centralized, user-friendly platform. Built on the foundation of Unity and supported by comprehensive QC data, Unity Next helps labs confidently make decisions to mitigate QC errors and protect patient safety.

At AACC 2023, Bio-Rad is also demonstrating how to streamline diabetes testing with fast and accurate smart HPLC and perform A1c testing without common hemoglobin variant interference. The company is demonstrating the D-100 hemoglobin testing system, a fully automated, best-in-class HbA1c analyzer for high-volume labs. The D-100 delivers more results with less effort with SMART HPLC, without sacrificing quality or workflow efficiency. In addition, Bio-Rad is demonstrating the BioPlex 2200 System, a fully automated, random-access, track line compatible, multiplex platform. BioPlex 2200 improves turnaround time, throughput, and overall workflow efficiency. With over 50 multiplex assays, the BioPlex System consolidates autoimmune, infectious disease, and vitamin D testing. One of the highlighted events during the conference is Bio-Rad’s industry workshop titled “A New Era in Laboratory Quality – Managing Molecular QC Data.” The workshop aims to provide attendees with valuable insights, including a discussion on molecular QC data management workflow improvements post-Unity implementation, a description of the value of Unity in evaluating the performance of viral load assays, and an identification of three essential functions of Unity for QC data management.

Related Links:
Bio-Rad Laboratories


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.